These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17575371)

  • 1. Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease.
    Okada T; Nakao T; Matsumoto H; Shino T; Nagaoka Y; Tomaru R; Wada T
    Intern Med; 2007; 46(12):807-14. PubMed ID: 17575371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis.
    Fukuoka K; Nakao K; Morimoto H; Nakao A; Takatori Y; Arimoto K; Taki M; Wada J; Makino H
    Nephrology (Carlton); 2008 Jun; 13(4):278-83. PubMed ID: 18476915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study.
    Hoshino J; Hamano T; Abe M; Hasegawa T; Wada A; Ubara Y; Takaichi K; Inaba M; Nakai S; Masakane I;
    Nephrol Dial Transplant; 2018 Jul; 33(7):1150-1158. PubMed ID: 29528439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycated albumin predicts the risk of mortality in type 2 diabetic patients on hemodialysis: evaluation of a target level for improving survival.
    Isshiki K; Nishio T; Isono M; Makiishi T; Shikano T; Tomita K; Nishio T; Kanasaki M; Maegawa H; Uzu T;
    Ther Apher Dial; 2014 Oct; 18(5):434-42. PubMed ID: 24251784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycated Albumin and Adverse Clinical Outcomes in Patients With CKD: A Prospective Cohort Study.
    Tang M; Berg AH; Zheng H; Rhee EP; Allegretti AS; Nigwekar SU; Karumanchi SA; Lash JP; Kalim S
    Am J Kidney Dis; 2024 Sep; 84(3):329-338. PubMed ID: 38518919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on hemodialysis.
    Yajima T; Yajima K; Hayashi M; Yasuda K; Takahashi H; Yamakita N
    J Diabetes Complications; 2016 Jul; 30(5):786-9. PubMed ID: 27009773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
    Sany D; Elshahawy Y; Anwar W
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients.
    Jun JE; Lee SE; Lee YB; Ahn JY; Kim G; Jin SM; Hur KY; Lee MK; Kim JH
    Cardiovasc Diabetol; 2017 Oct; 16(1):127. PubMed ID: 29017498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.
    Freedman BI; Andries L; Shihabi ZK; Rocco MV; Byers JR; Cardona CY; Pickard MA; Henderson DL; Sadler MV; Courchene LM; Jordan JR; Balderston SS; Graham AD; Mauck VL; Russell GB; Bleyer AJ
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1635-43. PubMed ID: 21597024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in glycated albumin levels predicts the progression of diabetic nephropathy.
    Park SB; Kim SS; Kim IJ; Nam YJ; Ahn KH; Kim JH; Jeon YK; Kim BH; Song SH; Kwak IS; Lee EK; Kim YK
    J Diabetes Complications; 2017 Jun; 31(6):1041-1046. PubMed ID: 28396158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycated albumin may be a choice, but not an alternative marker of glycated hemoglobin for glycemic control assessment in diabetic patients undergoing maintenance hemodialysis.
    Chen FK; Sun XF; Zhang D; Cui SY; Chen XM; Wei RB; Lu JM; Li JJ; Liu WH; Zhang DL; Zhang ZM
    Chin Med J (Engl); 2013; 126(17):3295-300. PubMed ID: 24033952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
    Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis.
    Kobayashi H; Abe M; Yoshida Y; Suzuki H; Maruyama N; Okada K
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycated albumin, not hemoglobin A1c, predicts cardiovascular hospitalization and length of stay in diabetic patients on dialysis.
    Murea M; Moran T; Russell GB; Shihabi ZK; Byers JR; Andries L; Bleyer AJ; Freedman BI
    Am J Nephrol; 2012; 36(5):488-96. PubMed ID: 23147746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.
    Copur S; Siriopol D; Afsar B; Comert MC; Uzunkopru G; Sag AA; Ortiz A; Covic A; van Raalte DH; Cherney DZ; Rossing P; Kanbay M
    Acta Diabetol; 2021 Jan; 58(1):81-91. PubMed ID: 32862262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of glycated albumin (GA) and GA/HbA1c ratio for diagnosis of diabetes and glycemic control: A comprehensive review.
    Yazdanpanah S; Rabiee M; Tahriri M; Abdolrahim M; Rajab A; Jazayeri HE; Tayebi L
    Crit Rev Clin Lab Sci; 2017 Jun; 54(4):219-232. PubMed ID: 28393586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of annual variability in HbA1c and glycated albumin in patients with type 1 vs. type 2 diabetes mellitus.
    Koga M; Murai J; Morita S; Saito H; Kasayama S
    J Diabetes Complications; 2013; 27(3):211-3. PubMed ID: 23312788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycated Albumin Predicts Long-term Survival in Patients Undergoing Hemodialysis.
    Lu CL; Ma WY; Lin YF; Shyu JF; Wang YH; Liu YM; Wu CC; Lu KC
    Int J Med Sci; 2016; 13(5):395-402. PubMed ID: 27226780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test.
    Nagayama H; Inaba M; Okabe R; Emoto M; Ishimura E; Okazaki S; Nishizawa Y
    Biomed Pharmacother; 2009 Mar; 63(3):236-40. PubMed ID: 18538530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.